| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 21/04/2021 | 22:07 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 13/04/2021 | 22:53 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 13/04/2021 | 15:35 | GlobeNewswire Inc. | Lixte Biotechnology Holdings, Inc. Announces the Appointment of Gil N Schwartzberg to its Board of Directors | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 26/03/2021 | 13:01 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 17/03/2021 | 14:35 | GlobeNewswire Inc. | Lixte Biotechnology to Present Its Novel Product Candidate for Targeted Cancer Therapy at the Benzinga Biotech Small Cap Conf... | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 03/03/2021 | 15:35 | GlobeNewswire Inc. | Lixte Biotechnology to Showcase Its Anti-Cancer Therapy Enhancer LB-100 at the Virtual 33rd Annual ROTH Capital Conference | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 03/03/2021 | 13:46 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 03/03/2021 | 00:38 | Business Wire | WestPark Capital Announces Completion of $4.19 Million Registered Direct Offering for Lixte Biotechnology Holdings, Inc. (Nas... | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 02/03/2021 | 21:41 | PR Newswire (US) | WallachBeth Capital Announces Completion of $4.19 Million Registered Direct Offering for Lixte Biotechnology Holdings, Inc. | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 02/03/2021 | 16:30 | GlobeNewswire Inc. | Lixte Biotechnology Announces the Closing of $4.19 Million Registered Direct Offering | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 01/03/2021 | 22:22 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 01/03/2021 | 14:45 | GlobeNewswire Inc. | Lixte Biotechnology Announces $4.19 Million Registered Direct Offering | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 24/02/2021 | 15:35 | GlobeNewswire Inc. | Lixte Biotechnology to Present Its Anti-Cancer Therapy Enhancer LB-100 at the Virtual H.C. Wainwright Global Life Sciences Co... | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 08/02/2021 | 12:05 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 26/01/2021 | 18:03 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 19/01/2021 | 15:35 | GlobeNewswire Inc. | Lixte Biotechnology and City of Hope to Initiate Phase 1b Clinical Trial of Lixte’s Lead Compound LB-100 to Treat Small Cel... | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 14/01/2021 | 20:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 17/12/2020 | 12:04 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 17/12/2020 | 12:02 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 01/12/2020 | 21:28 | PR Newswire (US) | WallachBeth Capital Announces Completion of $5.7 Million Joint Underwritten Public Offering for Lixte Biotechnology Holdings,... | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 01/12/2020 | 18:30 | GlobeNewswire Inc. | Lixte Biotechnology Holdings, Inc. Announces Closing of Public Offering and Uplisting to Nasdaq | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 30/11/2020 | 21:52 | Business Wire | WestPark Capital Announces Closing of $5,700,000 Follow-On Offering & NASDAQ Up-listing of Lixte Biotechnology Holdings, Inc.... | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 27/11/2020 | 23:25 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 25/11/2020 | 14:30 | GlobeNewswire Inc. | Lixte Biotechnology Holdings, Inc. Announces Pricing of $5,700,000 Public Offering; Uplisting to Nasdaq Capital Market and Re... | NASDAQ:LIXT | Lixte Biotechnology Holdings Inc |
| 02/07/2009 | 15:00 | PR Newswire (US) | Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models | NASDAQ:LIXT | |
| 20/10/2008 | 15:20 | PR Newswire (US) | Lixte Biotechnology Holdings Announces New Appointment to Board of Directors | NASDAQ:LIXT | |
| 19/08/2008 | 14:15 | PR Newswire (US) | Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by N | NASDAQ:LIXT | |
| 12/08/2008 | 16:18 | PR Newswire (US) | Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment | NASDAQ:LIXT | |
| 08/08/2008 | 15:15 | PR Newswire (US) | Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positi | NASDAQ:LIXT | |
| 25/06/2008 | 17:36 | PR Newswire (US) | Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institu | NASDAQ:LIXT | |